Includes a description of the overall structure of the guidance and the rationale behind the structure, the regulatory framework, roles of key personnel, procedures for the reporting of adverse incidents and defective equipment, and management of instruments potentially contaminated with transmissible spongiform encephalopathy (TSE) infectivity.